Kit for an inhaled chemotherapy comprising: a) a series of single hermetically packaged therapeutic doses of a dry powder for inhalation containing at least one anti-neoplastic agent chosen in the group of platinum drugs such as carboplatin, cisplatin, oxaliplatin, or nedaplatin with a lipid matrix b) a series of disposable dry powder inhaler devices, wherein i) each single hermetically packaged therapeutic dose having a closed state and an open state, ii) each disposable dry powder inhaler device having a closed position and an open position, iii) each single hermetically packaged therapeutic dose being provided for being accommodated in said closed state in one disposable dry powder inhaler device of said series of disposable dry powder inhaler devices, iv) and each single disposable dry powder inhaler device is provided to be in said closed position before or once each single hermetically packaged therapeutic dose become in said open state, wherein said single hermetically packaged therapeutic dose is a capsule or a blister and wherein each disposable dry powder inhaler device comprises a dispersion chamber in fluid connection with an inhalation channel and connected to a loading chamber for accommodating said single hermetically packaged therapeutic dose inside said disposable dry powder inhaler device, said loading chamber comprising activation means having an activated position and a rest position, said activated position being provided to open said single hermetically packaged therapeutic dose and locking means provided to prevent extraction of the single hermetically packaged therapeutic dose once said activation means have been moved to said activated position, or said activated position being provided to open said single hermetically packaged therapeutic dose and locking means having an open position and a lock position provided to prevent extraction of the single hermetically packaged therapeutic dose, said activation means being provided to be able to be moved to said activated position only when said locking means are in said lock position, or said disposable dry powder inhaler device comprising closing means provided to isolate the outside environment from the inside of the disposable dry powder inhaler device, in particular by closing the inhalation channel. a) a series of single hermetically packaged therapeutic doses of a dry powder for inhalation containing at least one anti-neoplastic agent chosen in the group of platinum drugs such as carboplatin, cisplatin, oxaliplatin, or nedaplatin with a lipid matrix b) a series of disposable dry powder inhaler devices, i) each single hermetically packaged therapeutic dose having a closed state and an open state, ii) each disposable dry powder inhaler device having a closed position and an open position, iii) each single hermetically packaged therapeutic dose being provided for being accommodated in said closed state in one disposable dry powder inhaler device of said series of disposable dry powder inhaler devices, iv) and each single disposable dry powder inhaler device is provided to be in said closed position before or once each single hermetically packaged therapeutic dose become in said open state, wherein said single hermetically packaged therapeutic dose is a capsule or a blister and wherein each disposable dry powder inhaler device comprises a dispersion chamber in fluid connection with an inhalation channel and connected to a loading chamber for accommodating said single hermetically packaged therapeutic dose inside said disposable dry powder inhaler device, said loading chamber comprising activation means having an activated position and a rest position, said activated position being provided to open said single hermetically packaged therapeutic dose and locking means provided to prevent extraction of the single hermetically packaged therapeutic dose once said activation means have been moved to said activated position, or said activated position being provided to open said single hermetically packaged therapeutic dose and locking means having an open position and a lock position provided to prevent extraction of the single hermetically packaged therapeutic dose, said activation means being provided to be able to be moved to said activated position only when said locking means are in said lock position, or said disposable dry powder inhaler device comprising closing means provided to isolate the outside environment from the inside of the disposable dry powder inhaler device, in particular by closing the inhalation channel.